The global blood ketone meter market size is expected to reach US$ 521.7 million by 2028 and is expected to increase at CAGR value of 7.2 % from 2021 to 2028. Blood ketone test meter evaluates the presence of ketones in blood. Ketones are the substances which are produced when the cells don’t get enough glucose. Ketones are generally found in blood or urine. Increased ketone level leads to diabetic ketoacidosis, a complication that leads to coma or death. A higher ketone level indicates weight reduction. A blood ketone test meter is used for checking diabetic ketoacidosis (DKA) in type 1 diabetic patients.
The growth in the ketone test meter market is identified by high ketone levels and diabetes. The growing geriatric population and increasing obese population are the driving factors for increasing demand for blood ketone test meters. Advancement in test meter, rising awareness about diabetes, health insurance, and reimbursement are the leading factors boosting the growth of the blood ketone market during the forecast period. From the data of the International Diabetes Federation (IDF) report, around 463 million adults of age group 20 to 79 years were suffering from diabetes globally in 2019 and is estimated to reach 700 million by 2045. However, according to the Centers for Disease Control and Prevention (CDC), around 30 per 1,000 patients were hospitalized due to diabetic ketoacidosis in the U.S. from 2009 to 2014. Blood Ketone meters are advanced devices that sometimes show faulty and inconsistent results which leads to product recall and this would reduce the popularity of these meters thereby restraining the market growth. Among the major geographies, North America is estimated to be the most dominant region in the global blood ketone meter market. Increasing product launches and approvals for new ketone meters by the government is expected to propel blood ketone market growth further.
The global blood ketone meter market is segmented on the basis of product type, application, end-use, and region. By product type, it is categorized into blood ketone monitoring, blood glucose, and ketone monitoring and consumables. On the basis of testing site, it is categorized into fingertip and alternate site testing. Patient care setting type is further bifurcated into type 1 and gestational diabetes. The application segment is classified into human and veterinary. By end-user, the market is categorized into hospitals, diagnostic centers, diagnostic centers, home care settings and others. Furthermore, on the basis of region it is categorized into North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Australia, and Rest of Asia Pacific), and Rest of the World (Latin America (Brazil, Mexico, Argentina, Colombia), Middle East & Africa (South Africa, Saudi Arabia, UAE)).
Key major players in the blood ketone meter market are Abbott Laboratories, ACON Laboratories Inc., Nipro Corporation, Keto-Mojo, PortaCheck Inc., Nova Biomedical, GlucoRx Limited, EKF Diagnostics Holdings Plc, Taidoc Technology Corporation, ForaCare Inc., Bruno MD, and Apex Biotechnology Corporation.
Global Blood Ketone Meter Market Segmentation and Scope
Global Ketone Meter Market is segmented on the basis of product type, testing site, patient care setting, application and region as mentioned below:
By Product Type
By Testing Site
By Patient Care Setting
Rest of the World
Middle East & Africa
The prominent players involved in the global blood ketone meter market includes